Philip Morris pivot from tobacco to healthcare with purchase of Vectura sparked opposition from doctors
Results offer hope of progress in combating bladder tumours and some forms of breast cancer
High rates of vomiting among those who took strong doses in trials have unsettled investors
Contact lens supplier is looking for buyers to separate from indebted parent company
Company’s chief oncology officer says reforms risk discouraging treatments for paediatric and rare conditions
GSK and AstraZeneca plan final trials to upgrade propellants that cause much of the sector’s carbon footprint
More aggressive actions and better co-ordinated responses needed to contain viruses, say public health experts
Early warning system requires roll out of latest testing techniques, Covid levels of co-operation and greater regulatory harmonisation
Danish pharma company also unveils early data for closely watched oral pill to tackle weight loss
Failure to reach statistical significance sets back effort to build oncology portfolio
Medical breakthroughs come with spiralling price tag, leaving policymakers with tough decisions
Police reportedly probing five current and former employees over infringement of data privacy laws
European Court of Auditors says closer co-operation on data and testing would help fix shortcomings exposed by Covid
US telehealth groups including Hims & Hers and Ro could find new revenue streams under threat
Scientists’ goal is not to resurrect vanished creatures but discover whether ancient molecules can solve modern problems
European Court of Justice says European Commission had no right to investigate tie-up
A three-part FT series looks at how an influx of money is changing prospects for patients but creating new challenges for healthcare systems
Pandemic winners BioNTech and Moderna face hurdles as they seek to bring their groundbreaking technology to oncology
More trials urged as part of effort to slow cognitive declines with existing medicines
Wealthy world must help Africa prevent a potential regional health catastrophe
Nice’s ruling on lecanemab demonstrates the lack of readiness to roll out new treatments in the UK
US group races to overcome production bottleneck to meet demand for anti-obesity medicine Zepbound
The first in an FT series looking at the new energy behind the fight for cancer cures
Pharma groups are finally turning their research focus to a huge unmet need
German healthcare group buys business that specialises in producing radioactive chemicals used in scans
